Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy
- Status
- TERMINATED
- Phase
- NA
Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO)
- Status
- COMPLETED
- Phase
- PHASE2
Study of GemOx and Vandetanib in Advanced Solid Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy and Radiation Following Pancreatic Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval
- Status
- UNKNOWN
- Phase
- PHASE3
Ph2 Gem/Nov/Rituxan Rel/Ref MantleCell
- Status
- COMPLETED
- Phase
- PHASE2
Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trial to Define the Safety and Tolerability of SGN-40, Rituximab, and Gemcitabine in Patients With DLBCL
- Status
- COMPLETED
- Phase
- PHASE1
Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001)
- Status
- COMPLETED
- Phase
- PHASE1